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Summary: Tuning liposomes for secretory phospholipase A2 
induced release of oxaliplatin results in enhanced anti-neoplastic 
effects in vitro and extensive toxicity in vivo. 
 
 
 
 
 
 
 
Introduction 
 
The clinical use of liposomal drug delivery vehicles is often hindered by insufficient drug 
release1. One compelling solution is utilizing an endogenous trigger mechanism that relies 
on a difference in the microenvironment of healthy and diseased tissue, such as the 
elevated expression of endogenous enzymes in cancerous tissues.  
 
Secretory phospholipase A2 (sPLA2) is an interfacially active lipase which functions mainly 
on organized substrates, such as lipid bilayers2, and it seems to have a preference for 
structural defects, such as domain boundaries3,4. We hypothesized that by adjusting the 
level of cholesterol in anionic, unsaturated liposomes we could tune the surface defects5,6, 
and as such tune the enzyme sensitivity, thus obtaining liposomes with an improved 
therapeutic outcome and reduced side effects.  
Results 
 
Conclusion 
 
Tuning the amount of cholesterol did not seem to considerably alter 
the enzyme sensitivity towards the novel sPLA2 sensitive liposomes 
(SSLs). Oxaliplatin loaded SSLs revealed efficient in vitro growth 
inhibition compared to clinically used stealth liposomes. However, 
treatment of nude NMRI mice induced severe toxicity, demonstrating 
that great caution should be implemented when using sPLA2 sensitive 
liposomes, and that the real utility can only be revealed in vivo.  
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Figure 1: Conceptual illustration. Liposome encapsulated oxaliplatin will circulate until it encounters the fenestrated capillaries in 
the tumor tissue, where it extravasates. Here it encounters an elevated level of secretory phospholipase A2 (sPLA2), which 
hydrolyses the phosphoglycerolipids, causing release of the drug. In addition the hydrolysis products, lyso-lipids and free fatty 
acids, may act as permeability enhancers, thus further contributing to drug transport across the cellular membrane.  
Figure 2: Enzymatic hydrolysis and release of 
oxaliplatin. A) POPC/POPG/Chol/DSPE-PEG2k 
liposomes with 0, 20 and 40 % cholesterol and 
HSPC/Chol/DSPE-PEG2k (Stealth) liposomes, 
loaded with oxaliplatin, were incubated in the 
presence or absence of secretory phospholipase A2 
(± sPLA2) at 37 °C with gentle magnetic stirring for 0, 
6 and 24 h. Release of oxaliplatin was determined by 
ICP-MS. Values are mean of three individual 
experiments ± SD. POPC/POPG/Chol/DSPE-PEG2k 
(35:40:20:5) liposomes were incubated with colo205 
cell conditioned media (CM), human tear fluid or no 
enzyme at 37 °C with gentle magnetic stirring for 6 h. 
Hydrolysis of B) POPC and C) POPG was 
determined by MALDI-TOF MS. DPPC was included 
as internal reference. Values are mean of a minimum 
of three lipid extractions and three spots of each 
extraction.   
Liposomal release of oxaliplatin is sPLA2 dependent, but only slightly cholesterol dependent   
Figure 3 In vitro cytotoxicity of oxaliplatin 
(OxPt) loaded sPLA2-sensitive liposomes. 
HT-29 cells were treated with an increasing 
amount of OxPt loaded POPC/POPG/Chol/
DSPE-PEG2k liposomes with 20 % 
cholesterol, either in the presence (open 
circles) or absence (open diamonds) of 
colo205 cell conditioned media containing 
sPLA2. OxPt in free form (closed circles) or 
encapsulated in HSPC/Chol/DSPE-PEG2k 
(Stealth) liposomes (closed diamonds) were 
used as controls. Cell survival was 
evaluated by MTS staining. Values are 
mean of triplicates with blank (media with 
MTS reagent) subtracted ± SD. All values 
are normalized to non-treated cells. The 
data is representative of minimum three 
separate experiments.  
Figure 4:In vivo effect of sPLA2 sensitive liposomes. A) Kaplan-Meier analysis of survival. Nude NMRI mice bearing MT-3 xenograft tumors were treated with 10 mg/kg free 
oxaliplatin (OxPt) (dotted line), OxPt loaded POPC/POPG/Chol/DSPE-PEG2k (35:40:20:5) liposomes (dashed line) or OxPt loaded Stealth liposomes (dotted dashed line) once 
per week for a total of four treatments. Isotonic glucose solution (solid line) was included as control. B) Mouse treated with OxPt loaded POPC/POPG/Chol/DSPE-PEG2k 
(35:40:20:5) liposomes, euthanized three days post first treatment due to excessive weight loss, dehydration and subcutaneous bleedings. C) Liver section from a mouse 
treated with OxPt loaded POPC/POPG/Chol/DSPE-PEG2k (35:40:20:5) liposomes. The liver section displays extensive multifocal necrosis of hepatocytes (white arrows) with 
collapse of hepatic sinusoids and hydropical injury to the cell nucleus of the hepatocytes. Several of the hepatocytes display nuclear inclusion bodies and vacuolar degeneration 
(white arrowheads). Extensive inflammatory reaction is seen in the hepatic sinusoids and around necrotic regions with accumulation of granulocytes (black arrows) (HE stained 
FFPE 5 um). .  
Liposomes show enhanced cytotoxic effect in vitro 
sPLA2 responsive liposomes induce severe toxicity in vivo 
Contact information: 
Ragnhild Garborg Østrem 
Technical University of Denmark 
ragga@nanotech.dtu.dk 
 
